United Kingdom (UK) – Healthcare, Regulatory and Reimbursement Landscape

GlobalData, the industry analysis specialist, has released its latest report, "United Kingdom (UK) – Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the UK. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The UK healthcare market is one of the most promising market globally, with universal health coverage and a strong focus on R&D in the field of genomics, artificial intelligence (AI), early-stage diagnostics, and big data. The UK pharmaceutical market increased from £13.77B in 2012 to £21.84B in 2019 at a Compound Annual Growth Rate (CAGR) of 6.8%. In terms of US Dollars, the market increased from $21.76B in 2012 to $29.42B in 2019 at a CAGR of 3.8%. It is forecast to reach about $35.52B in 2025. The key drivers contributing to the growth of the UK pharmaceutical market are universal healthcare coverage, the growing elderly population, increased access to healthcare services, high disease burden, and innovation in personalized medicines. However, the increased focus on generic drugs will be a barrier to the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the UK, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, GSK, AstraZeneca, and Merck

Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche Diagnostics, Siemens Healthineers, and Smith & Nephew

An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure

An overview of the opportunities for and challenges to growth in the UK healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving the UK’s healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the UK’s healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1. Table of Contents

1.1List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights – Facts about the UK Healthcare Market

2.3 Key Highlights: Healthcare Startups in the UK

2.4 Key Events: UK Healthcare Timeline, 2014-2021

2.5 Key Events: UK Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, UK, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, UK

3.5 Pharmaceutical Market – Market Segments

3.6 Major Therapeutic Areas, UK

3.7 COVID-19 Epidemiology, UK

3.8 COVID-19 Impact and Developments in the Healthcare Market, UK

3.9 COVID-19 Clinical Trials Landscape, UK

3.10 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, UK, 2020-2021

6.2 Deal Analysis: Medical Device Market, UK, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, UK

7.2Adoption of Technology in Healthcare, UK

7.3 HealthTech Deals Landscape, UK

7.4 Key HealthTech Deals, UK

7.5Key Developments: Collaborations and Deals Toward Digital Health, UK

7.6Key Developments: National AI Strategy, UK

7.7 Regulatory Scenario Covering Use of Technology in Healthcare, UK

7.8 HealthTech Landscape: Benefits and Risks, UK

8. Market Access

8.1 Overview of Healthcare System, UK

8.2 Reimbursement Process, UK

8.3 Overview of Insurance Providers, UK

8.4 Healthcare Spending and Consumer Price Index, UK

8.5 Pricing Policies, UK

8.6 Regulatory Landscape, UK

8.6.1 Overview of Regulatory Agencies

8.6.2 Marketing Authorization for Pharmaceutical Products, UK

8.6.3 Marketing Authorization for Biosimilars, UK

8.6.4 Marketing Authorization for Medical Devices, UK

8.6.5 Intellectual Property Rights, Patent, UK

8.6.6 Intellectual Property Rights, Trademark, UK

8.6.7 Clinical Trial Regulation, UK

8.6.8 Pharmaceutical Clinical Trials Landscape, UK

8.6.9 Medical Devices Clinical Trials Landscape, UK

8.6.10 Pharmaceutical Advertisement Regulations, UK

8.6.11 Pharmacy Regulations, UK

8.6.12 Labeling and Packaging Regulations, UK

8.6.13 Post-Brexit Impact on UK Healthcare Regulatory Landscape, UK

9. Country Healthcare Landscape

9.1Healthcare Policy Highlights, UK

9.2 Healthcare Facilities, UK

9.3 Healthcare Parameters, UK

9.4 Life Expectancy and Immunization Rate, UK

9.5 Environmental Health, UK

9.6 Healthcare Personnel, UK

9.7 Disease Burden, UK

9.8 Healthcare Expenditure, UK

10 Trade Associations, UK

11 Trade Fairs, UK

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

List of Tables

Table 1: COVID-19 Indicators (Number of Cases), UK and Global, 2020-2021

Table 2: COVID-19 Drugs (by Manufacturer Database), UK and Global, 2020-2021

Table 3: COVID-19 Vaccines Authorized, UK, 2020-2021

Table 4: Medical Devices Market, UK, Major Segments ($B), 2020

Table 5: General Surgery Devices Market, UK, Revenue ($B) and Market Share (%) of Major Companies, 2019

Table 6: Orthopedic Devices Market, UK, Revenue ($B) and Market Share (%) of Major Companies, 2019

Table 7: Cardiovascular Devices Market, UK, Revenue ($B) and Market Share (%) of Major Companies, 2019

Table 8: Wound Care Management Market, UK, Revenue ($B) and Market Share (%) of Major Companies, 2020

Table 9: Anesthesia and Respiratory Devices Market, UK, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 10: Patent Fees, 2020, UK

Table 11: Trademark Fees, 2020, UK

Table 12: Clinical Trials Application Fees, 2020, UK

Table 13: Clinical Trials Application Fees for Medical Devices, 2020, UK

Table 14: Post-Brexit Impact on UK Healthcare Regulatory Landscape, UK, 2021

Table 15: Conferences and Trade Fairs, UK, 2021

List of Figures

Figure 1: Pharmaceutical Market, UK, Revenue ($B), 2012-2020

Figure 2: Medical Devices Market, UK, Revenue ($B), 2015-2020

Figure 3: Healthcare Start-Ups in the UK, 2020

Figure 4: Country Profile, UK, 2020

Figure 5: Pharmaceutical Market, UK, Revenue ($B), 2012-2019

Figure 6: Pharmaceutical Market, UK, Revenue Forecast ($B), 2020-2025

Figure 7: Pharmaceutical Exports ($B), UK, 2012-2020

Figure 8: Top Export Partners, UK, 2020

Figure 9: Pharmaceutical Imports ($B), UK, 2012-2020

Figure 10: Top Import Partners, UK, 2020

Figure 11: Pharmaceutical Market, Supply Channel, UK, 2019

Figure 12: Generic Drugs Usage (% Share by Volume), UK, 2011-2019

Figure 13: Generic Drugs Usage (% Share by Value), UK, 2011-2019

Figure 14: NHS Genomic Medicine Centers, UK, 2020

Figure 15: Timeline of Cell and Gene Therapy Policies, UK, 2009-2021

Figure 16: OTC Medicines Market, Major Categories ($M), UK, 2019

Figure 17: OTC Medicines Market, Revenue ($B), UK, 2013-2020

Figure 18: OTC Medicines Market, Major Distribution Channels ($M), UK, 2020

Figure 19: Total Expenditure by Therapeutic Class ($B), UK, 2018

Figure 20: Major Therapeutic Areas by Pharmaceutical Sales (Million Units), UK, 2016-2018

Figure 21: COVID-19 (Number of Cases), UK, 2020-2021

Figure 22: COVID-19 (Number of Deaths), UK, 2020-2021

Figure 23: COVID-19-Related Travel Restrictions, UK, 2020-2021

Figure 24: COVID-19 Fiscal Stimulus Timeline, UK, 2020-2021

Figure 25: Vaccine Doses Administered per 1,000 People, UK, 2021

Figure 26: Top COVID-19 In Vitro Diagnostic Products by Type (Number of Available Marketed Products), UK, 2020-2021

Figure 27: Top COVID-19 IVD Products by Manufacturer (Number of Available Marketed Products), UK, 2020-2021

Figure 28: Top COVID-19 IVD Products by Application (Number of Available Marketed Products), UK, 2020-2021

Figure 29: Top COVID-19 IVD Products by Device Class (Number of Available Marketed Products), UK, 2020-2021

Figure 30: COVID-19 Clinical Trials Count by Phase, UK, 2020-2021

Figure 31: COVID-19 Clinical Trials Count by Trial Status, UK, 2020-2021

Figure 32: Top Five COVID-19 Clinical Trials Sponsors by Count, UK, 2020-2021

Figure 33: Pharmaceutical Market, Major Players, UK, 2020

Figure 34: Medical Devices Market, UK, Revenue ($B), 2015-2020

Figure 35: Medical Devices Market, UK, Revenue Forecast ($B), 2021-2025

Figure 36: Medical Devices Market, Major Segments (%), UK, 2020

Figure 37: General Surgery Devices Market, UK, Revenue ($B), 2017-2025

Figure 38: General Surgery Devices Market, UK, Market Share of Major Players (%), 2019

Figure 39: Orthopedic Devices Market, UK, Revenue ($B), 2017-2025

Figure 40: Orthopedic Devices Market, UK, Market Share of Major Players (%), 2019

Figure 41: Cardiovascular Devices Market, UK, Revenue ($B), 2017-2025

Figure 42: Cardiovascular Devices Market, UK, Market Share of Major Players (%), 2019

Figure 43: Wound Care Management Market, UK, Revenue ($B), 2017-2025

Figure 44: Wound Care Management Market, UK, Market Share of Major Players (%), 2020

Figure 45: Anesthesia and Respiratory Devices Market, UK, Revenue ($B), 2017-2025

Figure 46: Anesthesia and Respiratory Devices Market, UK, Market Share of Major Players (%), 2020

Figure 47: Diagnostic Market, UK, Revenue ($B), 2015-2020

Figure 48: Diagnostic Market, UK, Revenue ($B), 2021-2025

Figure 49: Medical Devices Market, Revenue ($B) of Major Companies, UK, 2019

Figure 50: Deal Value and Deal Count, Pharmaceutical Market, UK, 2020-2021

Figure 51: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, UK, 2020-2021

Figure 52: Deal Value and Deal Count Sub-types, Pharmaceutical Market, UK, 2020-2021

Figure 53: Top Therapy Areas by Deal Value ($B), Pharmaceutical Market, UK, 2020-2021

Figure 54: Top Therapy Areas by Deal Count, Pharmaceutical Market, UK, 2020-2021

Figure 55: M&A Deals by Quarter, Pharmaceutical Market, UK, 2020-2021 (by Value and by Number)

Figure 56: VC Deals by Quarter, Pharmaceutical Market, UK, 2020-2021 (by Value and by Number)

Figure 57: Deal Value and Deal Count, Medical Devices Market, UK, 2020-2021

Figure 58: Deal Value and Deal Count, Quarterly, Medical Devices Market, UK, 2020-2021

Figure 59: Deal Value and Deal Count Sub-types, Medical Devices Market, UK, 2020-2021

Figure 60: Top Equipment Areas by Deal Value ($B), Medical Devices Market, UK, 2020-2021

Figure 61: Top Equipment Areas by Deal Count, Medical Devices Market, UK, 2020-2021

Figure 62: M&A Deals by Quarter, Medical Devices Market, UK, 2020-2021 (by Value and by Number)

Figure 63: VC Deals by Quarter, Medical Devices Market, UK, 2020-2021 (by Value and by Number)

Figure 64: Adoption of Technology in Healthcare, UK, 2020

Figure 65: Deal Value ($B), HealthTech, UK, 2019-2020

Figure 66: Deal Count (Number of Deals), HealthTech, UK, 2019-2020

Figure 67: Recommendations for the Development of UK National AI Strategy, UK, 2020

Figure 68: Overview of Healthcare System, UK, 2020

Figure 69: Overview of Finance Flow, UK, 2020

Figure 70: NHS Departmental Expenditure Limit ($B), UK, 2015-2021

Figure 71: Market Access, Reimbursement Schemes, UK, 2020

Figure 72: OOP Expenditure (% of Health Spending), UK, 2012-2020

Figure 73: Annual Rate of Change (%), Consumer Price Index, Pharmaceutical

Products (Base Year 2015=100), UK, 2013-2020

Figure 74:Market Access, MHRA Structure, UK, 2020

Figure 75: Life Cycle of Medical Device, UK, 2018

Figure 76: App Labelling with UKCA Mark, Medical Device, UK, 2020

Figure 77: Patent Approval Process, UK, 2020

Figure 78: Trademark Approval Process, UK, 2020

Figure 79: Clinical Trial Authorization Application Flowchart, 2019, UK

Figure 80: Clinical Trial Regulation Process for Medical Devices, Market Access, 2020, UK

Figure 81: Pharmaceutical Clinical Trials Count by Trial Status, UK, 2019-2021

Figure 82: Pharmaceutical Clinical Trials Count by Phase, UK, 2019-2021

Figure 83: Pharmaceutical Clinical Trials Count by Indication, UK, 2019-2021

Figure 84: Top Five Pharmaceutical Clinical Trials Sponsors by Count, UK, 2019-2021

Figure 85: Medical Devices Clinical Trials Count by Trial Status, UK, 2019-2021

Figure 86: Medical Devices Clinical Trials Count by Device Category, UK, 2019-2021

Figure 87: Medical Devices Clinical Trials Count by Indication, UK, 2019-2021

Figure 88: Top Five Medical Devices Clinical Trials Sponsors by Count, UK, 2019-2021

Figure 89: Number of Publicly Owned Hospitals, UK, 2012-2018

Figure 90: Number of Diagnostic Equipment (Absolute Units per 1000 Population), UK, 2015-2021

Figure 91: Publicly Owned Hospital Beds (per 1,000 Population), UK, 2012-2019

Figure 92: Hospital Beds (per 1,000 Population), UK, 2012-2019

Figure 93: Psychiatric Care Hospital Beds (per 1,000 Population), UK, 2012-2019

Figure 94: Life Expectancy at Birth (Years), UK, 2012-2018

Figure 95: Immunization Rate (%), UK, 2013-2019

Figure 96: PM2.5 (µg per m3), UK, 2010-2017

Figure 97: CO2 Emissions (Mt CO2), UK, 2010-2019

Figure 98: Physicians (per 1,000 Population), US, 2010-2019

Figure 99: Dentists (per 1,000 Population), UK, 2012-2019

Figure 100: Pharmacists (per 1,000 Population), UK, 2012-2019

Figure 101: Nurses (per 1,000 Population), UK, 2012-2018

Figure 102: Major Causes of Mortality (Number of Deaths per 100,000 Population), UK, 2019

Figure 103: Major Causes of Male Mortality (Number of Deaths per 100,000 Population) UK, 2019

Figure 104: Major Causes of Female Mortality (Number of Deaths per 100,000 Population) UK, 2019

Figure 105: Disability-Adjusted Life Years by Major Disease (DALYS per 100,000 Population), UK, 2019

Figure 106: Healthcare Expenditure as Percentage of GDP (%), UK, 2010-2019

Figure 107: Healthcare Spending (Government versus Private), UK, 2010-2019

Figure 108: Healthcare Expenditure Components by Function (% of Total Health Expenditure), UK, 2018

Figure 109: Pharmaceutical Spending ($ per Capita), UK, 2010-2018

Figure 110: Opportunities and Challenges

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports